Confronting Molecular Bioanalysis Challenges in Gene Therapy Development
Confronting Molecular Bioanalysis Challenges in Gene Therapy DevelopmentBy Paul Byrne, Senior Director, Genomics, ProtaGene(PresseBox) (Heilbronn, 19.10.2023) As the gene therapy sector continues to mature, regulators’ expectations for more robust product understanding are growing. It’s excitin...
Source: pharmiweb.com